보고서 요약(국문)

개요
전 세계 심장 수술 기기 시장은 2022년 21억 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 3.4%의 성장률을 보이며 2030년에는 32억 달러에 이를 것으로 예상됩니다.
심장 수술 기기는 선천성 심장 질환, 부정맥, 심장 판막 질환 등 다양한 심혈관 질환 치료에 사용됩니다. 이러한 기기들은 손상되거나 막힌 판막과 동맥을 포함하여 심장 순환계의 구조적 문제를 치료하는 데 도움을 줍니다.
전 세계 심장 수술 기기 시장은 최근 몇 년 동안 심장 박동기, 이식형 심장 제세동기(ICD), 심장 판막, 풍선 카테터, 스텐트와 같은 심장 및 혈관 수술 기기의 사용 증가로 인해 상당한 성장을 보였습니다. 이러한 기기들은 심혈관 질환의 관리 및 치료에 중요한 역할을 합니다.

또한, 기술 발전, 신제품 출시, 유리한 의료비 상환 정책과 같은 주요 성장 동력이 향후 시장 성장을 견인할 것입니다. Medtronic plc, Terumo Corporation, LivaNova Plc., Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation 등 주요 기업들이 활발하게 시장에서 활동하고 있습니다.
시장 동향
심장 수술 기기의 기술 발전
심장 수술 기기는 허혈성 심장 질환, 류마티스성 심장 질환, 울혈성 심부전, 판막 심장 질환 등 다양한 심혈관 질환 치료에 사용됩니다. 주요 기업들의 핵심 기술 발전은 시장 성장을 촉진하는 데 기여하고 있습니다. 이러한 효과적인 기술 발전은 연구 결과를 새로운 치료법으로 전환하고 심장 질환을 앓고 있는 수백만 명의 환자들에게 더 나은 치료를 제공하는 데 도움이 됩니다.
예를 들어, 2023년 5월 Robocath는 EuroPCR 2023 학회에서 관상동맥 성형술용 로봇 수술 시스템인 R-One+를 출시했습니다. 이 플랫폼을 통해 심장 전문의는 심혈관 조영술실에 설치된 제어 명령 장치를 통해 기기를 제어할 수 있습니다.
또한, 2022년 12월 애보트 연구소는 최신 세대 경피적 대동맥판막 이식술(TAVI) 시스템인 네비터(Navitor)를 출시하여 수술 위험이 높거나 매우 높은 중증 대동맥 협착증 환자에게 최소 침습 기기를 제공했습니다. 따라서 위의 요인들로 인해 시장은 예측 기간 동안 성장할 것으로 예상됩니다.
우호적인 의료비 상환 정책이 심장 수술 기기 시장 성장을 촉진하고 있습니다.
의료비 상환 정책은 시술의 복잡성, 사용되는 카테터의 종류, 시술 중 사용되는 의료 자원과 같은 요소를 고려하는 경우가 많습니다. 의료비 상환 정책은 심장 카테터 시술을 수행하는 의료 서비스 제공자에게 제공되는 보장 수준과 재정적 상환액을 결정하기 때문에 심장 수술 기기 시장에서 중요한 역할을 합니다.

예를 들어, Shockwave Medical의 2022년 7월 보고서에 따르면, 2021년 초 관상동맥 IVL 출시 이후 Shockwave는 보험금 지급 측면에서 상당한 진전을 이루었습니다. 외래, 외래수술센터(ASC), 입원 환자 모두에서 보험금 지급이 가능합니다. 또한, 관상동맥 카테고리 III CPT 코드를 통해 의사 보험금 지급 기회도 있습니다.
심장 카테터 시술의 합병증이 시장 성장을 저해할 것입니다.
심장 카테터 시술은 혈관에 카테터를 삽입하는 시술로, 혈관 손상을 유발할 수 있습니다. 혈관 천공, 박리(혈관벽 파열), 파열 등이 발생할 수 있습니다. 혈관 손상은 출혈, 혈종 형성으로 이어지거나 수술적 치료가 필요할 수도 있습니다.
CardioVascular Group의 2023년 4월 보고서에 따르면, 심장 카테터 시술과 관련된 가장 흔한 위험은 출혈입니다. 시술 중 카테터 삽입을 위해 작은 절개를 하는데, 이로 인해 출혈이 발생할 수 있습니다. 심장 카테터 삽입술 중 또는 후에 부정맥이라고 불리는 심장 박동 이상이 발생할 수 있습니다. 이는 시술 중 혈류 변화 또는 카테터가 심장 근육에 마찰을 일으켜 발생할 수 있습니다.
세그먼트 분석
전 세계 심장 수술 기기 시장은 제품, 시술, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 부문 중 카테터는 전 세계 심장 수술 기기 시장 점유율의 약 47.2%를 차지했습니다.
카테터 삽입술은 일반적으로 대동맥 전위증이나 폐동맥 폐쇄증과 같이 심방 사이의 비정상적인 연결 또는 불충분한 혈류가 있는 특정 선천성 심장 결함이 있는 환자에게 다양한 카테터를 사용하여 시행됩니다. 심혈관 질환 발병률 증가로 인해 카테터에 대한 수요가 증가하고 있습니다.

예를 들어, 2023년 5월 애보트 연구소(Abbott Laboratories)는 센서가 장착된 세계 최초의 유연한 팁과 접촉력 기술을 갖춘 절제 카테터인 택티플렉스(TactiFlex)에 대해 미국 식품의약국(FDA)의 승인을 받았습니다.
또한, 2022년 5월 메드트로닉(Medtronic Plc.)은 표재성 대퇴동맥 및 슬와동맥의 말초동맥질환(PAD) 중재적 치료에 사용되는 약물 코팅 풍선(DCB)인 IN.PACT 018 파클리탁셀 코팅 경피적 혈관성형술(PTA) 풍선 카테터에 대해 미국 식품의약국(FDA)의 승인을 받았습니다.

지리적 시장 침투
북미는 2022년 시장 점유율의 약 38.5%를 차지했습니다.
북미는 최근 몇 년간 심장 수술 기기 시장에서 상당한 비중을 유지해 왔으며, 미국 내 개심술 건수 증가와 심장 수술 기기 기술 발전 등의 요인으로 인해 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.
예를 들어, 라이프스팬 헬스 시스템(Lifespan Health System)에 따르면 미국에서는 매년 약 50만 건의 개심술이 시행됩니다. 심장 수술 기기는 관상동맥 우회술이나 대동맥 또는 심장 자체에 대한 복잡한 시술과 같은 고난도 수술에 주로 사용됩니다. 또한, 관상동맥 질환은 가장 흔한 심장 질환 유형으로, 2021년에 375,476명의 사망자를 발생시켰습니다.
경쟁 환경
시장의 주요 글로벌 업체로는 Medtronic Plc., Terumo Corporation, LivaNova Plc., Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation, Getinge AB, Wexler Surgical, Lepu Medical Technology Co. Ltd, Gore Medical Inc. 등이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 심장 수술 기기 시장에 상당한 영향을 미쳤습니다. 2020년 초 팬데믹 발생으로 인해 광범위한 봉쇄와 제한 조치가 시행되었고, 이는 전 세계적으로 정기 검진, 진료 예약, 기기 이식 및 상담에 영향을 미쳤습니다. 많은 병원이 COVID-19 환자 치료에 집중하면서 선천성 심장 결함을 앓고 있는 많은 환자의 심장 수술이 감소했습니다.
또한, 팬데믹 기간 동안 연구 개발 노력의 초점이 COVID-19 백신 및 치료제 개발에 맞춰졌습니다. 따라서 위와 같은 요인들로 인해 심장 수술 기기 시장은 예측 기간 동안 다소 영향을 받을 것으로 예상됩니다.
제품별 분류
• 심장박동 수술 시스템
o 안정기
o 위치 고정기
• 심폐 바이패스 장비
o 동맥 캐뉼라
o 정맥 캐뉼라
o 산소 공급기
• 카테터
o 풍선 카테터
o 절제 카테터
o 배액 카테터
• 관류 소모품
o 동맥 필터
o 커넥터
o 혈액 농축기
• 기타
시술별 분류
• 관상동맥 우회술
• 최소 침습 수술
• 기타
적용 분야별 분류
• 선천성 심장 질환
• 관상동맥 질환
• 부정맥
• 심장 판막 질환
• 류마티스성 심장 질환
• 대동맥류
• 울혈성 심부전
• 기타
최종 사용자별 분류
• 병원
• 심장 센터
• 외래 수술 센터
• 기타
지역별 분류
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
• 2023년 3월, Shockwave Medical은 새로운 말초 IVL 카테터를 출시했습니다. Shockwave L6 카테터는 장골 동맥 및 대퇴 동맥을 포함한 주요 말초 혈관에서 치료가 어려운 병변의 석회화를 개선하기 위해 특별히 설계되었습니다.

• 2023년 6월, Terumo Aortic은 복잡한 대동맥궁 질환 환자 치료를 위해 미국 식품의약국(FDA)의 승인을 받은 유일한 냉동 코끼리 코(FET) 장치인 Thoraflex Hybrid에 대한 글로벌 시판 후 연구(PAS)인 EXTEND를 시작했습니다.
보고서를 구매해야 하는 이유? • 제품, 시술, 적용 분야, 최종 사용자 및 지역별 글로벌 심장 수술 기기 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 글로벌 심장 수술 기기 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 심장 수술 기기 시장 보고서는 약 69개의 표, 70개의 그림, 195페이지 분량입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Cardiac Surgery Devices Market reached US$ 2.1 billion in 2022 and is expected to reach US$ 3.2 billion by 2030 growing with a CAGR of 3.4% during the forecast period 2023-2030.
Cardiac surgery devices are used in the treatment of many cardiovascular diseases including congenital heart disease, arrhythmias, and heart valve disease. Cardiac surgery devices aid in the healing of structural problems in the circulatory system of the heart including damaged or clogged valves and arteries.
The global cardiac surgery devices market has witnessed significant growth in recent years due to the usage of cardiac and vascular surgery devices such as pacemakers, implantable cardioverter defibrillators (ICDs), heart valves, balloon catheters, and stents as they play a key role in managing and treating cardiovascular diseases.
Furthermore, significant growth drivers such as increasing technological advancements, product launches, and favorable reimbursement policies give rise to future market growth. Significant key players like Medtronic plc, Terumo Corporation, LivaNova Plc., Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation, and others are actively operating in the market.
Dynamics
Technological Advancements in Cardiac Surgery Devices
Cardiac surgery devices are used to treat many cardiovascular diseases such as ischemic heart disease, rheumatic heart disease, congestive heart failure, and valvular heart disease. The major technological advancements by major companies help to drive market growth. These effective advancements help to transform research discoveries into new treatments and improve care for millions of people with heart diseases.
For instance, in May 2023, Robocath launched a robot system for heart surgery called R-One+, for coronary angioplasties at the EuroPCR 2023 conference. The platform allows the cardiologist to control devices from the control command unit which can be positioned in the catheterization laboratory.
Additionally, in December 2022, Abbott Laboratories launched its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, by making the minimally invasive device available for people with severe aortic stenosis who are at high or extreme surgical risk. Hence, due to the above factors, the market is expected to boost over the forecast period.
Favorable Reimbursement Policies are Boosting the Cardiac Surgery Device Market
Reimbursement policies often consider factors such as the complexity of the procedure, the type of catheter used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the cardiac surgery device market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing cardiac catheterization procedures.
For instance, according to Shockwave Medical July 2022, since the launch of Coronary IVL in early 2021, Shockwave has made deep and significant progress on reimbursement. They have reimbursement in the outpatient, ASC, and inpatient settings. In addition, an opportunity for physician reimbursement via Coronary Category III CPT code.
Complications for Cardiac Catheterization Will Hamper the Growth of the Market
Cardiac catheterization involves the insertion of a catheter into blood vessels, which can potentially cause vessel damage. This can include vessel perforation, dissection (tearing of the vessel wall), or rupture. Vessel damage can result in bleeding, hematoma formation, or even require surgical repair.
According to CardioVascular Group, April 2023, the most common risk associated with cardiac catheterization is bleeding. During the procedure, a small incision is made to insert the catheter, and this can lead to bleeding. Heart rhythm abnormalities called arrhythmias can happen during or after cardiac catheterization. These can result from changes in blood flow during the procedure or from the catheter rubbing against the heart muscle.
Segment Analysis
The global cardiac surgery devices market is segmented based on product, procedure, application, end users, and region.
Catheters from the Product Segment Accounted for Approximately 47.2% of the Global Cardiac Surgery Devices Market Share
The catheterization procedure is typically carried out in patients by using various catheters with certain congenital heart defects, such as transposition of the great arteries or pulmonary atresia, where there is an abnormal communication or inadequate blood flow between the atria. The demand for catheters is driven by the increasing incidence of cardiovascular diseases.
For instance, in May 2023, Abbott Laboratories received the approval of the U.S. Food and Drug Administration (FDA) for the company's TactiFlex Ablation Catheter which is sensor-enabled and the world's first ablation catheter with a flexible tip and contact force technology.
Additionally, in May 2022, Medtronic Plc. received approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug-coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.
Geographical Penetration
North America Accounted for Approximately 38.5% of the Market Share in 2022
North America has maintained a significant proportion of the cardiac surgery devices market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as the rising number of open heart surgeries performed in the U.S. and technological advancements in cardiac surgery devices.
For instance, according to the Lifespan Health System, there are about 500,000 open heart surgeries performed each year in the United States. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. Also, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021.
Competitive Landscape
The major global players in the market include Medtronic Plc., Terumo Corporation, LivaNova Plc., Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation, Getinge AB, Wexler Surgical, Lepu Medical Technology Co. Ltd, and Gore Medical Inc. among others.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the cardiac surgery device market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular check-ups, appointments, device implantations, and consultations worldwide. Many hospitals are focused on COVID-19 cases, and this reduced cardiac surgery in many patients suffering from congenital heart defects.
Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the cardiac surgery device market is expected to be moderately affected over the forecast period.
By Product
• Beating Heart Surgery Systems
o Stabilizers
o Positioners
• Cardiopulmonary Bypass Equipment
o Arterial cannula
o Venous cannula
o Oxygenators
• Catheters
o Balloon catheter
o Ablation Catheter
o Drainage Catheter
• Perfusion Disposables
o Arterial Filters
o Connectors
o Hemoconcentrator
• Others
By Procedure
• Coronary Artery Bypass Grafting
• Minimally Invasive Surgery
• Others
By Application
• Congenital Heart Disease
• Coronary Artery Disease
• Arrhythmias
• Heart Valve Disease
• Rheumatic Heart Disease
• Aortic Aneurysm
• Congestive Heart Failure
• Others
By End Users
• Hospital
• Cardiac Centers
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In March 2023, Shockwave Medical launched the new peripheral IVL catheter. The Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat lesions in large peripheral vessels, including the iliac and the common femoral arteries.
• In June 2023, Terumo Aortic launched of the company’s global post-approval study (PAS) known as EXTEND for Thoraflex Hybrid, the only frozen elephant trunk (FET) device approved by the US Food and Drug Administration (FDA) for the treatment of patients with complex aortic arch disease.
Why Purchase the Report?
• To visualize the global cardiac surgery devices market segmentation based on product, procedure, application, end users, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global cardiac surgery devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global cardiac surgery devices market report would provide approximately 69 tables, 70 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Procedure
3.3. Snippet by Applications
3.4. Snippet by End Users
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements in cardiac surgery devices
4.1.1.2. Favorable reimbursement policies
4.1.2. Restraints
4.1.2.1. Complications for cardiac catheterization
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Beating Heart Surgery System
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Stabilizers
7.2.4. Positioners
7.3. Cardiopulmonary Bypass Equipment
7.3.1. Arterial cannula
7.3.2. Venous cannula
7.3.3. Oxygenators
7.4. Catheters
7.4.1. Balloon catheter
7.4.2. Ablation Catheter
7.4.3. Drainage Catheter
7.5. Perfusion Disposables
7.5.1. Arterial Filters
7.5.2. Connectors
7.5.3. Hemoconcentrator
8. By Procedure
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
8.1.2. Market Attractiveness Index, By Procedure
8.2. Coronary Artery Bypass Grafting
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Minimally Invasive Surgery
8.4. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Congenital Heart Disease
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Coronary Artery Disease
9.4. Arrhythmias
9.5. Heart Valve Disease
9.6. Others
10. By End Users
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.1.2. Market Attractiveness Index, By End Users
10.2. Hospitals
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cardiac Centers
10.4. Ambulatory Surgical Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Product Benchmarking
12.3. Company Share Analysis
12.4. Key Developments and Strategies
13. Company Profiles
13.1. Medtronic Plc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Terumo Corporation
13.3. LivaNova Plc
13.4. Abbott Laboratories
13.5. Murray Surgical Limited
13.6. Boston Scientific Corporation
13.7. Getinge AB
13.8. Wexler Surgical
13.9. Lepu Medical Technology Co. Ltd.
13.10. Gore Medical Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Medtronic Plc, 4.	Key Developments, Terumo Corporation, LivaNova Plc, Abbott Laboratories, Murray Surgical Limited, Boston Scientific Corporation, Getinge AB, Wexler Surgical, Lepu Medical Technology Co. Ltd., Gore Medical Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Cardiac Surgery Devices Market Value, By Product, 2022, 2026 & 2030 (US$ Billion)

Table 2 Global Cardiac Surgery Devices Market Value, By Procedure, 2022, 2026 & 2030 (US$ Billion)

Table 3 Global Cardiac Surgery Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Billion)

Table 4 Global Cardiac Surgery Devices Market Value, By End Users, 2022, 2026 & 2030 (US$ Billion)

Table 5 Global Cardiac Surgery Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 6 Global Cardiac Surgery Devices Market Value, By Product, 2022, 2026 & 2030 (US$ Billion)

Table 7 Global Cardiac Surgery Devices Market Value, By Product, 2021-2030 (US$ Billion)

Table 8 Global Cardiac Surgery Devices Market Value, By Procedure, 2022, 2026 & 2030 (US$ Billion)

Table 9 Global Cardiac Surgery Devices Market Value, By Procedure, 2021-2030 (US$ Billion)

Table 10 Global Cardiac Surgery Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Billion)

Table 11 Global Cardiac Surgery Devices Market Value, By Application, 2021-2030 (US$ Billion)

Table 12 Global Cardiac Surgery Devices Market Value, By End Users, 2022, 2026 & 2030 (US$ Billion)

Table 13 Global Cardiac Surgery Devices Market Value, By End Users, 2021-2030 (US$ Billion)

Table 14 Global Cardiac Surgery Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 15 Global Cardiac Surgery Devices Market Value, By Region, 2021-2030 (US$ Billion)

Table 16 North America Cardiac Surgery Devices Market Value, By Product, 2021-2030 (US$ Billion)

Table 17 North America Cardiac Surgery Devices Market Value, By Procedure, 2021-2030 (US$ Billion)

Table 18 North America Cardiac Surgery Devices Market Value, By Application, 2021-2030 (US$ Billion)

Table 19 North America Cardiac Surgery Devices Market Value, By End Users, 2021-2030 (US$ Billion)

Table 20 North America Cardiac Surgery Devices Market Value, By Country, 2021-2030 (US$ Billion)

Table 21 South America Cardiac Surgery Devices Market Value, By Product, 2021-2030 (US$ Billion)

Table 22 South America Cardiac Surgery Devices Market Value, By Procedure, 2021-2030 (US$ Billion)

Table 23 South America Cardiac Surgery Devices Market Value, By Application, 2021-2030 (US$ Billion)

Table 24 South America Cardiac Surgery Devices Market Value, By End Users, 2021-2030 (US$ Billion)

Table 25 South America Cardiac Surgery Devices Market Value, By Country, 2021-2030 (US$ Billion)

Table 26 Europe Cardiac Surgery Devices Market Value, By Product, 2021-2030 (US$ Billion)

Table 27 Europe Cardiac Surgery Devices Market Value, By Procedure, 2021-2030 (US$ Billion)

Table 28 Europe Cardiac Surgery Devices Market Value, By Application, 2021-2030 (US$ Billion)

Table 29 Europe Cardiac Surgery Devices Market Value, By End Users, 2021-2030 (US$ Billion)

Table 30 Europe Cardiac Surgery Devices Market Value, By Country, 2021-2030 (US$ Billion)

Table 31 Asia-Pacific Cardiac Surgery Devices Market Value, By Product, 2021-2030 (US$ Billion)

Table 32 Asia-Pacific Cardiac Surgery Devices Market Value, By Procedure, 2021-2030 (US$ Billion)

Table 33 Asia-Pacific Cardiac Surgery Devices Market Value, By Application, 2021-2030 (US$ Billion)

Table 34 Asia-Pacific Cardiac Surgery Devices Market Value, By End Users, 2021-2030 (US$ Billion)

Table 35 Asia-Pacific Cardiac Surgery Devices Market Value, By Country, 2021-2030 (US$ Billion)

Table 36 Middle East & Africa Cardiac Surgery Devices Market Value, By Product, 2021-2030 (US$ Billion)

Table 37 Middle East & Africa Cardiac Surgery Devices Market Value, By Procedure, 2021-2030 (US$ Billion)

Table 38 Middle East & Africa Cardiac Surgery Devices Market Value, By Application, 2021-2030 (US$ Billion)

Table 39 Middle East & Africa Cardiac Surgery Devices Market Value, By End Users, 2021-2030 (US$ Billion)

Table 40 Medtronic: Overview

Table 41 Medtronic: Product Portfolio

Table 42 Medtronic: Key Developments

Table 43 Terumo Corporation: Overview

Table 44 Terumo Corporation: Product Portfolio

Table 45 Terumo Corporation: Key Developments

Table 46 LivaNova: Overview

Table 47 LivaNova: Product Portfolio

Table 48 LivaNova: Key Developments

Table 49 Abbott Laboratories: Overview

Table 50 Abbott Laboratories: Product Portfolio

Table 51 Abbott Laboratories: Key Developments

Table 52 Murray Surgicals: Overview

Table 53 Murray Surgicals: Product Portfolio

Table 54 Murray Surgicals: Key Developments

Table 55 Boston Scientific: Overview

Table 56 Boston Scientific: Product Portfolio

Table 57 Boston Scientific: Key Developments

Table 58 Getinge: Overview

Table 59 Getinge: Product Portfolio

Table 60 Getinge: Key Developments

Table 61 Wexler Surgical: Overview

Table 62 Wexler Surgical: Product Portfolio

Table 63 Wexler Surgical: Key Developments

Table 64 Lepu Medical Technology: Overview

Table 65 Lepu Medical Technology: Product Portfolio

Table 66 Lepu Medical Technology: Key Developments

Table 67 Gore Medical: Overview

Table 68 Gore Medical: Product Portfolio

Table 69 Gore Medical: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 2 Global Cardiac Surgery Devices Market Share, By Product, 2022 & 2030 (%)

Figure 3 Global Cardiac Surgery Devices Market Share, By Procedure, 2022 & 2030 (%)

Figure 4 Global Cardiac Surgery Devices Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Cardiac Surgery Devices Market Share, By End Users, 2022 & 2030 (%)

Figure 6 Global Cardiac Surgery Devices Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Cardiac Surgery Devices Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 8 Beating Heart Surgery Systems Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 9 Cardiopulmonary Bypass Equipment Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 10 Catheters Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 11 Perfusion Disposables Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 12 Global Cardiac Surgery Devices Market Y-o-Y Growth, By Procedure, 2022-2030 (%)

Figure 13 Coronary Artery Bypass Grafting Procedure in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 14 Minimally Invasive Surgery Procedure in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 15 Others Procedure in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 16 Global Cardiac Surgery Devices Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 17 Conginital Heart Disease Application in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 18 Coronary Artery Disease Application in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 19 Arrhythmias Application in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 20 Heart Valve Disease Application in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 21 Global Cardiac Surgery Devices Market Y-o-Y Growth, By End Users, 2022-2030 (%)

Figure 22 Hospitals End Users in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 23 Ambulatory Surgical Centers End Users in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 24 Others End Users in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 25 End Users in Global Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 26 Global Cardiac Surgery Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 27 North America Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 28 Asia-Pacific Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 29 Europe Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 30 South America Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 31 Middle East and Africa Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 32 North America Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 33 North America Cardiac Surgery Devices Market Share, By Product, 2022 & 2030 (%)

Figure 34 North America Cardiac Surgery Devices Market Share, By Procedure, 2022 & 2030 (%)

Figure 35 North America Cardiac Surgery Devices Market Share, By Application, 2022 & 2030 (%)

Figure 36 North America Cardiac Surgery Devices Market Share, By End Users, 2022 & 2030 (%)

Figure 37 North America Cardiac Surgery Devices Market Share, By Country, 2022 & 2030 (%)

Figure 38 South America Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 39 South America Cardiac Surgery Devices Market Share, By Product, 2022 & 2030 (%)

Figure 40 South America Cardiac Surgery Devices Market Share, By Procedure, 2022 & 2030 (%)

Figure 41 South America Cardiac Surgery Devices Market Share, By Application, 2022 & 2030 (%)

Figure 42 South America Cardiac Surgery Devices Market Share, By End Users, 2022 & 2030 (%)

Figure 43 South America Cardiac Surgery Devices Market Share, By Country, 2022 & 2030 (%)

Figure 44 Europe Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 45 Europe Cardiac Surgery Devices Market Share, By Product, 2022 & 2030 (%)

Figure 46 Europe Cardiac Surgery Devices Market Share, By Procedure, 2022 & 2030 (%)

Figure 47 Europe Cardiac Surgery Devices Market Share, By Application, 2022 & 2030 (%)

Figure 48 Europe Cardiac Surgery Devices Market Share, By End Users, 2022 & 2030 (%)

Figure 49 Europe Cardiac Surgery Devices Market Share, By Country, 2022 & 2030 (%)

Figure 50 Asia-Pacific Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 51 Asia-Pacific Cardiac Surgery Devices Market Share, By Product, 2022 & 2030 (%)

Figure 52 Asia-Pacific Cardiac Surgery Devices Market Share, By Procedure, 2022 & 2030 (%)

Figure 53 Asia-Pacific Cardiac Surgery Devices Market Share, By Application, 2022 & 2030 (%)

Figure 54 Asia-Pacific Cardiac Surgery Devices Market Share, By End Users, 2022 & 2030 (%)

Figure 55 Asia-Pacific Cardiac Surgery Devices Market Share, By Country, 2022 & 2030 (%)

Figure 56 Middle East & Africa Cardiac Surgery Devices Market Value, 2021-2030 (US$ Billion)

Figure 57 Middle East & Africa Cardiac Surgery Devices Market Share, By Product, 2022 & 2030 (%)

Figure 58 Middle East & Africa Cardiac Surgery Devices Market Share, By Procedure, 2022 & 2030 (%)

Figure 59 Middle East & Africa Cardiac Surgery Devices Market Share, By Application, 2022 & 2030 (%)

Figure 60 Middle East & Africa Cardiac Surgery Devices Market Share, By End Users, 2022 & 2030 (%)

Figure 61 Medtronic: Financials

Figure 62 Terumo Corporation: Financials

Figure 63 LivaNova: Financials

Figure 64 Abbott Laboratories: Financials

Figure 65 Murray Surgicals: Financials

Figure 66 Boston Scientific: Financials

Figure 67 Getinge: Financials

Figure 68 Wexler Surgical: Financials

Figure 69 Lepu Medical Technology: Financials

Figure 70 Gore Medical: Financials

글로벌 심장 수술 기기 시장 – 2023-2030

Global Cardiac Surgery Devices Market - 2023-2030